Mirae Asset Capital

Mirae Asset Capital accounts for 11 tracked companies with verified cap-table data, 11 of which disclose round sizes totalling $1.4B. The median disclosed raise is $114M, and the largest is Dewpoint Therapeutics at $287M, ahead of O-House ($261M) and ROME Therapeutics ($199M).

The names that recur most often on these portfolio cap tables are Mirae Asset Capital (11 companies), IMM Investment (3 companies), SBI Investment (3 companies), BOND (2 companies), Korea Development Bank (2 companies), Andreessen Horowitz (2 companies). By latest disclosed round, the market skews Series B (6), Series D (2), Series C (1), Series A (1).

• Companies tracked: 11
• Disclosed funding total: $1.4B across 11 companies
• Median disclosed raise: $114M
• Largest raise: Dewpoint Therapeutics — $287M
• Stage mix: Series B 6 · Series D 2 · Series C 1 · Series A 1
• Most recent dated round: 2026-06-01

Best funded Mirae Asset Capital companies

1. Dewpoint Therapeutics — $287M (latest: Series C)
2. O-House — $261M (latest: Series D)
3. ROME Therapeutics — $199M (latest: Series B)
4. XCENA — $185M (latest: Series B)
5. Promethera Biosciences — $132M (latest: Series D)
6. Woebot Health — $114M (latest: Series B)
7. Isovalent — $69M (latest: Series B)
8. Levit — $67M (latest: Series B)
9. MetisX — $50M (latest: Series A)
10. StyleShare — $46M
11. Ignis — $35M (latest: Series B)

Mirae Asset Capital Life Science — related firms and companies (45)

• Accent Therapeutics
• Precede Biosciences
• Mirae Asset Capital Life Science co-investors 2026
• Investors like Mirae Asset Capital Life Science
• Companies backed by Mirae Asset Capital Life Science
• Investors like Alexandria Venture Investments
• Investors like DCM Ventures
• Investors like B Capital
• Investors like Venrock
• Investors like Greycroft
• Investors like Slow Ventures
• Investors like Index Ventures
• Investors like Bienville Capital
• Investors like 137 Ventures
• Investors like Amino Capital
• Investors like Motivate Venture Capital
• Investors like Crossbeam Venture Partners
• Investors like Eniac Ventures
• Investors like Polaris Partners
• Investors like Foundation Capital
• Investors like Felicis
• Investors like Khosla Ventures
• Investors like Oak HC/FT
• Investors like Ribbit Capital
• Investors like Amplify Partners
• Investors like Fika Ventures
• Investors like Franklin Templeton
• Investors like Atlas Venture
• Investors like Wellington Management
• Investors like Bain Capital Ventures
• Investors like Insight Partners
• Investors like Blockchain Capital
• Investors like Altos Ventures
• Investors like Capital One Ventures
• Investors like Peak XV Partners
• Investors like Digital Currency Group
• Investors like Lux Capital
• Investors like Sapphire Ventures
• Investors like Initialized Capital
• Investors like Google Ventures
• Investors like Bessemer Venture Partners
• Investors like The Westly Group
• Investors like Ridge Ventures
• Investors like Bling Capital
• Investors like Point72 Ventures

Mirae Asset Capital Life Science profile · All research reports